Prevymis (letermovir) - Merck (MSD)
Updating CMV protocols in lung transplant patients: a single-center case study modeling use of generative AI for antimicrobial stewardship protocol development and economic impact analysis. (PubMed, Infect Control Hosp Epidemiol) - Jun 9, 2026 - "The AI-proposed protocol was less cost-effective, but data suggest that careful prompting can provide appropriate PubMed-indexed literature to support ASP protocol development. Additionally, CoPilotTM provided a thorough cost-effectiveness analysis comparing all potential and existing protocols. With appropriate oversight, AI and Microsoft CopilotTM can conduct healthcare economic analyses suitable for ASP strategic planning and implementation." 
HEOR • Journal • Cytomegalovirus Infection • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42252971
 
Augusto Dulanto Chiang; Casey Smiley; Kyle T Enriquez; Milner Staub
 
Jun 9, 2026
 
Prev Next